Search results for: 'vitro diagnostic test landscape'

This research service evaluates the Western European cancer IVD market for Germany, the United Kingdom, Italy, Spain, France, Benelux and Scandinavia from 2010 to 2019. Beginning with an overview of the main market metrics and trends, the study identifies the key market drivers and restraints, evaluates ongoing competitive trends with detailed mark...

This study provides data for the Western European in vitro diagnostics (IVD) market. Haematology, haemostasis, urinalysis, microbiology, clinical chemistry, point-of-care testing, molecular diagnostics, tissue diagnostics, self-monitoring blood glucose and immunochemistry are the segments within this market. Market revenues have been included in th...

The aim of this research service is to thoroughly assess and analyse the in vitro diagnostics market in Western European countries and provide strategic recommendations and conclusions for the success of market participants. This study provides an understanding of the key segments (immunochemistry, microbiology, molecular diagnostics, POCT, SMBG, t...

19 Jan 2024  |  Europe  |  Market Research

European Non-invasive Prenatal Testing Market, Forecast to 2028

Driving Progress in Screening Techniques Amplifies Accessibility and Adoption of NIPT, Cultivating a Broader Patient Engagement in Europe

Infographics

×

The European non-invasive prenatal testing (NIPT) market will experience significant growth thanks to technological advancement, increasing awareness among expectant parents, and the rising incidence of chromosomal abnormalities in fetuses. The market has experienced a surge in demand due to its products non-invasive nature compared to traditional...

01 Jul 2016  |  Europe  |  Market Research

Western Europe Point-of-Care Testing (POCT) Market

Infographics

×

Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the indu...

This research service provides an analysis of various aspects of the molecular diagnostics market in Europe for the years 2007 - 2015. The market has been divided into four segments: infectious diseases, genetic diseases, oncology and pharmacogenomics. The market has been covered segment wise, as well as geography wise, covering seven countries and...

The objective of this study is to assess the market potential of current testing areas pertaining to the area of genetics such as diagnostic testing/screeening, relationship testing and predictive testing. Revenue forecast has been provided for 2010-2018 for each segment within the United Kingdom, Germany, France, Italy, Spain, Scandinavia and Bene...

The increase in HIV awareness among people has led to the demand for effective diagnostic products and solutions. As a result, some new products based on NAT technology and non-NAT technology platforms are being developed. This research service analyses the HIV diagnostics market in Europe, particularly, HIV NAT diagnostics and HIV Immunodiagnostic...

This strategic analysis service provides detailed analysis of the European IVD market. The service, in powerpoint format (approximately 115 slides), focuses not only on the revenue and competitor analysis but also on the strategies for achieving success in this highly competitive market.